VAR2CSA Domain-Specific Analysis of Naturally Acquired Functional Antibodies to Plasmodium falciparum Placental Malaria.

BACKGROUND Placental malaria is caused by Plasmodium falciparum-infected erythrocytes (IEs) that surface-express VAR2CSA and bind chondroitin sulfate A. The inflammatory response to placenta-sequestered parasites is associated with poor pregnancy outcomes, and protection may be mediated in part by VAR2CSA antibodies that block placental IE adhesion. METHODS In this study, we used a new approach to assess VAR2CSA domains for functional epitopes recognized by naturally acquired antibodies. Antigen-specific immunoglobulin (Ig) G targeting Duffy binding-like (DBL) domains from different alleles were sequentially purified from plasma pooled from multigravid women and then characterized using enzyme-linked immunosorbent assay, flow cytometry, and antiadhesion assays. RESULTS Different DBL domain-specific IgGs could react to homologous as well as heterologous antigens and parasites, suggesting that conserved epitopes are shared between allelic variants. Homologous blocking of IE binding was observed with ID1-DBL2-ID2a-, DBL4-, and DBL5-specific IgG (range, 42%-75%), whereas partial cross-inhibition activity was observed with purified IgG specific to ID1-DBL2-ID2a and DBL4 antigens. Plasma retained broadly neutralizing activity after complete depletion of these VAR2CSA specificities. CONCLUSIONS Broadly neutralizing antibodies of multigravidae are not depleted on VAR2CSA recombinant antigens, and hence development of VAR2CSA vaccines based on a single construct and variant might induce antibodies with limited broadly neutralizing activity.

[1]  A. Wey,et al.  Comparison of the specificity of antibodies to VAR2CSA in Cameroonian multigravidae with and without placental malaria: a retrospective case–control study , 2015, Malaria Journal.

[2]  M. Fried,et al.  Designing a VAR2CSA-based vaccine to prevent placental malaria , 2015, Vaccine.

[3]  T. Theander,et al.  The Influence of Sub-Unit Composition and Expression System on the Functional Antibody Response in the Development of a VAR2CSA Based Plasmodium falciparum Placental Malaria Vaccine , 2015, PloS one.

[4]  S. Reed,et al.  Reversible Conformational Change in the Plasmodium falciparum Circumsporozoite Protein Masks Its Adhesion Domains , 2015, Infection and Immunity.

[5]  P. Deloron,et al.  Protective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, Benin , 2015, Emerging infectious diseases.

[6]  A. Craig,et al.  Investigating the function of Fc‐specific binding of IgM to P lasmodium falciparum erythrocyte membrane protein 1 mediating erythrocyte rosetting , 2015, Cellular microbiology.

[7]  B. Gamain,et al.  Llama immunization with full-length VAR2CSA generates cross-reactive and inhibitory single-domain antibodies against the DBL1X domain , 2014, Scientific Reports.

[8]  P. Deloron,et al.  Dynamics in the Cytoadherence Phenotypes of Plasmodium falciparum Infected Erythrocytes Isolated during Pregnancy , 2014, PloS one.

[9]  P. Bigey,et al.  Differential adhesion-inhibitory patterns of antibodies raised against two major variants of the NTS-DBL2X region of VAR2CSA. , 2013, Vaccine.

[10]  Joseph D. Smith,et al.  Identification of VAR2CSA Domain-Specific Inhibitory Antibodies of the Plasmodium falciparum Erythrocyte Membrane Protein 1 Using a Novel Flow Cytometry Assay , 2013, Clinical and Vaccine Immunology.

[11]  Danny W. Wilson,et al.  Defining the Antigenic Diversity of Plasmodium falciparum Apical Membrane Antigen 1 and the Requirements for a Multi-Allele Vaccine against Malaria , 2012, PloS one.

[12]  Joseph D. Smith,et al.  Multilaboratory Approach to Preclinical Evaluation of Vaccine Immunogens for Placental Malaria , 2012, Infection and Immunity.

[13]  T. Theander,et al.  Structural and Functional Insight into How the Plasmodium falciparum VAR2CSA Protein Mediates Binding to Chondroitin Sulfate A in Placental Malaria* , 2012, The Journal of Biological Chemistry.

[14]  X. Ambroggio,et al.  Analysis of the Conformation and Function of the Plasmodium falciparum Merozoite Proteins MTRAP and PTRAMP , 2012, Eukaryotic Cell.

[15]  D. Scherman,et al.  The NTS-DBL2X region of VAR2CSA induces cross-reactive antibodies that inhibit adhesion of several Plasmodium falciparum isolates to chondroitin sulfate A. , 2011, The Journal of infectious diseases.

[16]  P. Andersen,et al.  Differential Induction of Functional IgG Using the Plasmodium falciparum Placental Malaria Vaccine Candidate VAR2CSA , 2011, PloS one.

[17]  T. Theander,et al.  High efficacy of anti DBL4ɛ-VAR2CSA antibodies in inhibition of CSA-binding Plasmodium falciparum-infected erythrocytes from pregnant women. , 2011, Vaccine.

[18]  C. Lim,et al.  Chondroitin Sulfate A-Adhering Plasmodium falciparum-Infected Erythrocytes Express Functionally Important Antibody Epitopes Shared by Multiple Variants , 2010, The Journal of Immunology.

[19]  A. Scherf,et al.  Strain-Transcendent Immune Response to Recombinant Var2CSA DBL5-ε Domain Block P. falciparum Adhesion to Placenta-Derived BeWo Cells under Flow Conditions , 2010, PloS one.

[20]  T. Theander,et al.  Several domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies , 2010, Malaria Journal.

[21]  A. Jin,et al.  Structure of the Plasmodium falciparum Circumsporozoite Protein, a Leading Malaria Vaccine Candidate* , 2009, The Journal of Biological Chemistry.

[22]  T. Theander,et al.  Induction of Adhesion-Inhibitory Antibodies against Placental Plasmodium falciparum Parasites by Using Single Domains of VAR2CSA , 2009, Infection and Immunity.

[23]  T. Theander,et al.  VAR2CSA expression on the surface of placenta-derived Plasmodium falciparum-infected erythrocytes. , 2008, The Journal of infectious diseases.

[24]  A. Thomas,et al.  A Diversity-Covering Approach to Immunization with Plasmodium falciparum Apical Membrane Antigen 1 Induces Broader Allelic Recognition and Growth Inhibition Responses in Rabbits , 2008, Infection and Immunity.

[25]  Joseph D. Smith,et al.  Evidence for Globally Shared, Cross-Reacting Polymorphic Epitopes in the Pregnancy-Associated Malaria Vaccine Candidate VAR2CSA , 2008, Infection and Immunity.

[26]  A. Saul,et al.  Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines. , 2008, Vaccine.

[27]  A. Oleinikov,et al.  Six Genes Are Preferentially Transcribed by the Circulating and Sequestered Forms of Plasmodium falciparum Parasites That Infect Pregnant Women , 2007, Infection and Immunity.

[28]  J. Lebowitz,et al.  Production and characterization of clinical grade Escherichia coli derived Plasmodium falciparum 42 kDa merozoite surface protein 1 (MSP1(42)) in the absence of an affinity tag. , 2006, Protein expression and purification.

[29]  Stephen J Rogerson,et al.  VAR2CSA is the principal ligand for chondroitin sulfate A in two allogeneic isolates of Plasmodium falciparum. , 2006, Molecular and biochemical parasitology.

[30]  T. Theander,et al.  Dynamics of anti-VAR2CSA immunoglobulin G response in a cohort of senegalese pregnant women. , 2006, The Journal of infectious diseases.

[31]  M. C. Bolla,et al.  Maternal Malaria and Gravidity Interact to Modify Infant Susceptibility to Malaria , 2005, PLoS medicine.

[32]  Michael Lanzer,et al.  A single member of the Plasmodium falciparum var multigene family determines cytoadhesion to the placental receptor chondroitin sulphate A , 2005, EMBO reports.

[33]  Hong Zhou,et al.  Posttranslational Modification of Recombinant Plasmodium falciparum Apical Membrane Antigen 1: Impact on Functional Immune Responses to a Malaria Vaccine Candidate , 2005, Infection and Immunity.

[34]  P. Deloron,et al.  Variable adhesion abilities and overlapping antigenic properties in placental Plasmodium falciparum isolates. , 2004, The Journal of infectious diseases.

[35]  D. Gowda,et al.  Plasmodium falciparum-infected erythrocytes adhere both in the intervillous space and on the villous surface of human placenta by binding to the low-sulfated chondroitin sulfate proteoglycan receptor. , 2004, The American journal of pathology.

[36]  E. J. Mann,et al.  Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes and adhesion inhibitory antibodies are associated with placental malaria and have overlapping and distinct targets. , 2004, The Journal of infectious diseases.

[37]  Kevin Marsh,et al.  Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria , 2004, The Lancet.

[38]  M. Fried,et al.  Antibodies That Inhibit Plasmodium falciparum Adhesion to Chondroitin Sulfate A Are Associated with Increased Birth Weight and the Gestational Age of Newborns , 2003, Infection and Immunity.

[39]  A. Holder,et al.  The Human Immune Response to Plasmodium falciparum Includes Both Antibodies That Inhibit Merozoite Surface Protein 1 Secondary Processing and Blocking Antibodies , 2002, Infection and Immunity.

[40]  M. Valiyaveettil,et al.  Gravidity-Dependent Production of Antibodies That Inhibit Binding of Plasmodium falciparum-Infected Erythrocytes to Placental Chondroitin Sulfate Proteoglycan during Pregnancy , 2001, Infection and Immunity.

[41]  T. Theander,et al.  Plasma Antibodies from Malaria-Exposed Pregnant Women Recognize Variant Surface Antigens on Plasmodium falciparum-Infected Erythrocytes in a Parity-Dependent Manner and Block Parasite Adhesion to Chondroitin Sulfate A1 , 2000, The Journal of Immunology.

[42]  P. Deloron,et al.  Development of Antibodies against Chondroitin Sulfate A-Adherent Plasmodium falciparum in Pregnant Women , 1999, Infection and Immunity.

[43]  François Nosten,et al.  Maternal antibodies block malaria , 1998, Nature.

[44]  M. Fried,et al.  Maternal malaria and parasite adhesion , 1998, Journal of Molecular Medicine.

[45]  R. Snow,et al.  Malaria is an important cause of anaemia in primigravidae: evidence from a district hospital in coastal Kenya. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[46]  R. Steketee,et al.  The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity, and intrauterine growth retardation in rural Malawi. , 1996, The American journal of tropical medicine and hygiene.

[47]  Patrick E. Duffy,et al.  Adherence of Plasmodium falciparum to Chondroitin Sulfate A in the Human Placenta , 1996, Science.

[48]  M. Molyneux,et al.  Placental monocyte infiltrates in response to Plasmodium falciparum malaria infection and their association with adverse pregnancy outcomes. , 2003, The American journal of tropical medicine and hygiene.

[49]  B. Brabin.  An analysis of malaria in pregnancy in Africa. , 1983, Bulletin of the World Health Organization.